Search Results - "MUSSON, Donald G"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Acetylator Status Impacts Amifampridine Phosphate (Firdapse™) Pharmacokinetics and Exposure to a Greater Extent Than Renal Function by Haroldsen, Peter E., PhD, Sisic, Zlatko, MD, Datt, Joe, MD, Musson, Donald G., PhD, Ingenito, Gary, MD, PhD

    Published in Clinical therapeutics (01-07-2017)
    “…Abstract Purpose The purpose of this study is to evaluate safety, tolerability, and pharmacokinetic (PK) properties of amifampridine phosphate (Firdapse™) and…”
    Get full text
    Journal Article
  5. 5

    Effects of Food Intake on the Relative Bioavailability of Amifampridine Phosphate Salt in Healthy Adults by Haroldsen, Peter E., PhD, Musson, Donald G., PhD, Hanson, Boyd, PhD, Quartel, Adrian, MD, O’Neill, Charles A., PhD

    Published in Clinical therapeutics (01-07-2015)
    “…Abstract Purpose Amifampridine (3,4-diaminopyridine) has been approved in the European Union for the treatment of Lambert-Eaton myasthenic syndrome…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9

    Application of a novel ultra-low elution volume 96-well solid-phase extraction method to the LC/MS/MS determination of simvastatin and simvastatin acid in human plasma by Yang, Amy Y., Sun, Li, Musson, Donald G., Zhao, Jamie J.

    “…A novel extraction method has been utilized in the LC/MS/MS determination of simvastatin and simvastatin acid in human plasma. In this method, 300 μl of plasma…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    High turbulence liquid chromatography online extraction and tandem mass spectrometry for the simultaneous determination of suberoylanilide hydroxamic acid and its two metabolites in human serum by Du, Lihong, Musson, Donald G., Wang, Amy Qiu

    Published in Rapid communications in mass spectrometry (01-01-2005)
    “…A reliable and sensitive method incorporating high turbulence liquid chromatography (HTLC) online extraction with tandem mass spectrometry (MS/MS), for…”
    Get full text
    Journal Article
  13. 13
  14. 14

    A new approach for evaluating carryover and its influence on quantitation in high-performance liquid chromatography and tandem mass spectrometry assay by Zeng, Wei, Musson, Donald G., Fisher, Alison L., Wang, Amy Qiu

    Published in Rapid communications in mass spectrometry (01-01-2006)
    “…In a high‐performance liquid chromatography (HPLC)‐based analytical method, carryover denotes one type of systematic error that is derived from a preceding…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Assay methodology for the quantitation of unbound ertapenem, a new carbapenem antibiotic, in human plasma by Musson, Donald G, Birk, Kimberly L, Kitchen, Chester J, Zhang, Jin, Hsieh, John Y.K, Fang, Wei, Majumdar, Anup K, Rogers, John D

    “…Ertapenem is a new once-a-day antibiotic with excellent coverage of common community gram negative and gram positive aerobes and anaerobes. It demonstrates…”
    Get full text
    Journal Article
  17. 17

    Pharmacokinetic and Pharmacodynamic Evaluation of Elosulfase Alfa, an Enzyme Replacement Therapy in Patients with Morquio A Syndrome by Qi, Yulan, Musson, Donald G., Schweighardt, Becky, Tompkins, Troy, Jesaitis, Lynne, Shaywitz, Adam J., Yang, Ke, O’Neill, Charles A.

    Published in Clinical pharmacokinetics (01-12-2014)
    “…Background and Objectives Morquio A syndrome (mucopolysaccharidosis IVA; MPS IVA) is a lysosomal storage disorder caused by deficiency of N…”
    Get full text
    Journal Article
  18. 18

    High-throughput liquid chromatography for drug analysis in biological fluids: investigation of extraction column life by Zeng, Wei, Fisher, Alison L, Musson, Donald G, Wang, Amy Qiu

    “…A novel method was developed and assessed to extend the lifetime of extraction columns of high-throughput liquid chromatography (HTLC) for bioanalysis of human…”
    Get full text
    Journal Article
  19. 19

    A Prospective Population Pharmacokinetic Analysis of Sapropterin Dihydrochloride in Infants and Young Children with Phenylketonuria by Qi, Yulan, Mould, Diane R., Zhou, Huiyu, Merilainen, Markus, Musson, Donald G.

    Published in Clinical pharmacokinetics (01-02-2015)
    “…Background and Objectives Untreated phenylketonuria (PKU), a hereditary metabolic disorder caused by a genetic mutation in phenylalanine hydroxylase (PAH), is…”
    Get full text
    Journal Article
  20. 20

    Maternal phenylketonuria syndrome: studies in mice suggest a potential approach to a continuing problem by Zeile, William L, McCune, Helen C, Musson, Donald G, O'Donnell, Brian, O'Neill, Charles A, Tsuruda, Laurie S, Zori, Roberto T, Laipis, Philip J

    Published in Pediatric research (01-04-2018)
    “…Background Untreated phenylketonuria (PKU), one of the most common human genetic disorders, usually results in mental retardation. Although a…”
    Get full text
    Journal Article